Obesity-induced dyslipidemia has been identified as “metabolic-related dyslipidemia” [49], which is mainly driven by the effects of insulin resistance and proinflammatory adipokines [10]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.